Table 1 Summary of clinical data for the entire population
From: Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
Clinical Variables | HCM | p value | Controls |
|---|---|---|---|
Number | 40 | 20 | |
Male (n) | 30(75%) | 0.9 | 16(80%) |
Age (years) | 40 ± 14 | 0.6 | 38 ± 10 |
CMR findings: | |||
LV mass index (g/m2) | 107 ± 36 | <0.0001 | 64 ± 14 |
EDVi (ml/m2) | 77 ± 17 | 0.8 | 78 ± 12 |
Maximal ED thickness (mm) | 19 ± 5 | <0.0001 | 9 ± 4 |
Ejection fraction (%) | 68 ± 10 | 0.24 | 65 ± 8 |